- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07943832
Blended Eclectic Programme to Improve Community Preparedness for Acute Myocardial Infarction (BE-Prepared)
Enhancing Chest Pain Centre Services With the Blended Eclectic Programme to Improve Community Preparedness for Acute Myocardial Infarction: An Effectiveness-implementation Hybrid Study
Coronary artery disease (CAD) is the leading cause of death and disability worldwide, and acute myocardial infarction (AMI, commonly known as heart attack) is its most severe and life-threatening form. In a heart attack, the time from symptoms onset to the receipt of reperfusion therapy to restore blood flow ("total ischaemic time") strongly influences how much heart muscle is saved and whether the patient survives. The longer the delay, the worse the outcome.
Despite effort to reduce in-hospital delay through establishment of chest pain centres, a critical gap remains. The time taken by patients to recognise symptoms and seek care during the prehospital stage accounts for the largest proportion of total ischaemic time. This study proposes the "Blended Eclectic Programme for Optimising Community Preparedness (BE-Prepared)" to improve timely care-seeking behaviours among CAD patients and the general public, ultimately reducing prehospital delays and improving AMI patient outcomes in Hong Kong. This programme consists of two components: a community-based health education component and a narrative intervention for CAD patients.
It is hypothesised that CAD patients who receive the BE-Prepared programme, compared with those receiving usual care, will show greater improvements in behavioural intention to seek care for AMI symptoms, better AMI knowledge, and fewer perceived barriers to care-seeking. It is further hypothesised that CAD patients who receive the programme will report a shorter onset-to-door time, be more likely to use an ambulance, and have reduced in-hospital stays and fewer 30-day major adverse cardiac and cerebrovascular events following an AMI episode relative to the control group.
The study uses a type 2 effectiveness-implementation hybrid design, combining a randomised controlled trial with a qualitative study to evaluate both whether the programme works and how it can be integrated into routine practice. Adults aged ≥18 with confirmed CAD but no prior AMI will be recruited from three major Hong Kong public hospitals and randomly assigned 1:1 to BE-Prepared or usual care. Outcomes will be assessed at baseline, 3 months, and 12 months, with 12-month monitoring for acute coronary events, guided by the RE-AIM framework. Healthcare providers will join SWOT workshops and selected patients will be interviewed. If effective, BE-Prepared could close a critical gap in current services, reducing prehospital delay and improving AMI outcomes in Hong Kong.
Обзор исследования
Статус
Подробное описание
Acute myocardial infarction (AMI) is a highly time-sensitive emergency in which treatment delay is associated with larger infarct size, more complications, and higher mortality. A key prognostic determinant is total ischaemic time, the interval from symptom onset to reperfusion therapy. Although clinical guidelines recommend a system delay of under 60 minutes from diagnosis to wire crossing during primary percutaneous coronary intervention, and Hong Kong is establishing chest pain centres (CPCs) from July 2025 to reduce in-hospital delays, the prehospital interval remains the largest contributor to total ischaemic time.
Care-seeking is a complex perceptual-cognitive process requiring accurate symptom attribution, perceived susceptibility to a life-threatening event, and the influence of contextual factors such as competing responsibilities and external prompts. Therefore, this study proposes a comprehensive, theory-driven approach-the Blended Eclectic programme for optimising community Preparedness (BE-Prepared)-to improve timely care-seeking behaviours among CAD patients and the general public.
The study adopts a type 2 effectiveness-implementation hybrid design, simultaneously assessing clinical effectiveness and implementation with equal priority. It comprises a prospective, assessor-blinded, two-arm randomised controlled trial (RCT) to evaluate the effects of the BE-Prepared programme among CAD patients, and a qualitative study to gather stakeholder insights on the implementation process. Following written informed consent, participants will be randomly allocated in a 1:1 ratio to the intervention group (BE-Prepared programme) or the control group (usual care). The BE-Prepared programme consists of two components: a community-based health education component and a narrative intervention for CAD patients. Allocation will be concealed. A research assistant will ask participants to select a sealed envelope corresponding to a computer-generated random number, assigning them to the intervention or control group.
CAD participants will be recruited from three major public hospitals providing emergency cardiac care. Recruitment will be publicised through social media and the patient self-help organisation. Eligible participants will receive a verbal explanation supplemented by an information sheet and must sign an informed consent form prior to data collection, receiving a signed copy. A baseline assessment lasting approximately 30 minutes will be scheduled. Healthcare providers for the SWOT analysis will be recruited from cardiac wards at three major hospitals and will attend a 1.5-hour SWOT workshop to identify barriers and facilitators to integrating BE-Prepared into routine CAD care. The sample size was calculated based on prior findings from a theory-based narrative intervention developed by the project team for AMI survivors, in which effect sizes for attitudes and beliefs regarding care-seeking were 0.34 and 0.41 at 12 months post-intervention. Using PASS 2021, 175 participants per arm provide 80% power at a 5% two-sided significance level to detect an effect size of 0.30. Allowing for a 20% dropout rate, 438 participants will be recruited (219 per group) for the two-arm RCT, together with 45 healthcare professionals for the SWOT analysis across the participating hospitals.
Descriptive statistics will summarise reach, adoption, and maintenance data. Baseline homogeneity between study groups will be assessed using the independent t-test, chi-square test, or Fisher's exact test as appropriate. Generalised estimating equations (GEE) will compare changes in outcome variables across T0, T1, and T2 between groups, accounting for intra-correlated repeated measures and accommodating randomly missing data due to incomplete attendance or dropout. Between-group differences in symptom onset-to-door (O2D) time and ambulance use among participants experiencing an AMI by T2 will be assessed using the independent t-test and chi-square test. A generalised linear model with an appropriate link function will compare major adverse cardiovascular and cerebrovascular event (MACCE) episodes, hospital readmissions, and length of stay. Analyses will follow an intention-to-treat approach; all tests will be two-sided with p < 0.05 considered statistically significant, conducted in IBM SPSS 29.0. Qualitative interview data will be audio-recorded, transcribed verbatim, and cross-checked against the original recordings by the lead principal investigator. Content analysis will code participants' perceptions, engagement experience, and the acceptability of the intervention, and will explore how and why the programme influences care-seeking behaviours and intentions. To enhance trustworthiness, an audit trail will be maintained and two investigators will independently code the qualitative data.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Dr. Polly Wai-Chi Li, PhD
- Номер телефона: +852 39176686
- Электронная почта: pwcli@hku.hk
Места учебы
-
-
-
Hong Kong, Гонконг
- Queen Mary Hospital
-
Контакт:
- Dr. Polly Wai-Chi Li, PhD
- Номер телефона: +852 39176686
- Электронная почта: pwcli@hku.hk
-
Hong Kong, Гонконг
- Prince of Wales Hospital
-
Контакт:
- Dr. Polly Wai-Chi Li, PhD
- Номер телефона: +852 39176686
- Электронная почта: pwcli@hku.hk
-
Hong Kong, Гонконг
- Queen Elizabeth Hospital
-
Контакт:
- Dr. Polly Wai-Chi Li, PhD
- Номер телефона: +852 39176686
- Электронная почта: pwcli@hku.hk
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
For participants for the BE-Prepared programme
Inclusion Criteria:
- Adults with age ≥18 years
- Residing in the community
- Confirmed CAD diagnosis
- Without a prior history of AMI; and
- Access to an internet-enabled device
Exclusion Criteria:
- Individuals who do not understand Cantonese
- Individuals who have impaired communication, psychiatric problems or cognitive impairment (i.e., Abbreviated Mental Test ≤6)
For health providers participating in the SWOT analysis
Inclusion Criteria:
- Full-time staff (doctors, nurses and social workers) in the Cardiac department of the study hospital who involve in providing care to cardiac patients
Exclusion Criteria:
- Health care providers with part-time employment
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Профилактика
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Intervention group
Participants will receive usual care, access to the community-based health education initiative, and the five-week blended narrative intervention comprising one face-to-face workshop followed by four weekly web-based modules with nurse-facilitated interactive sessions. |
The BE-Prepared programme consist of 2 components: a community-based health education initiative and a five week narrative intervention.
|
|
Активный компаратор: Control group
Participants will receive usual care, comprising unstructured health education provided by the healthcare team, and access to the community-based health education initiative. They will not receive the structured five-week narrative intervention. |
The usual care includes unstructured health education provided by the healthcare team and access to the community-based health education component of this project. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Care-seeking attitudes and beliefs for AMI symptoms, measured by the Acute Coronary Syndrome Response Index (ACSRI)
Временное ограничение: At baseline (T0), 3 months (T1) and 12 months (T2) post-programme
|
The Acute Coronary Syndrome Response Index-Chinese version (ACSRI-C) will be used to assess patients' attitudes and knowledge regarding AMI care-seeking. The ACSRI has good reliability (Cronbach's alphas: 0.76-0.82) and discriminant validity. It consists of a total of 33 questions divided into 3 scales measuring knowledge, attitudes, and belief. The attitudes subscale consists of 5 items, while the beliefs subscale consists of 7 items. Participants respond on a 4-point Likert scale. The higher subscale total scores (range for the attitudes subscale, 5-20; range for the beliefs subscale, 7-28) indicate more appropriate care-seeking attitudes and beliefs. |
At baseline (T0), 3 months (T1) and 12 months (T2) post-programme
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Knowledge of AMI symptoms
Временное ограничение: At baseline (T0), 3 months (T1) and 12 months (T2) post-programme
|
AMI knowledge was measured using the knowledge subscale of the ACSRI-C. This subscale consists of 21 items to be answered dichotomously (yes/no). The correct items are summed (range, 0-21), and a higher total score represents greater knowledge |
At baseline (T0), 3 months (T1) and 12 months (T2) post-programme
|
|
Perceived barriers to care-seeking, measured by the 10-item Perceived Barriers to Health Care-seeking Decision (PBHSD) scale
Временное ограничение: At baseline (T0), 3 months (T1) and 12 months (T2) post-programme
|
The 10-item Perceived Barriers to Health Care-seeking Decision (PBHSD) will be used to measure perceived barriers to care-seeking when patients experience AMI symptoms. Each item is rated on a 6-point Likert scalewith"1" indicating strongly disagree and "6" indicating strongly agree. The sum of scores on each item gives the overall score. The possible range of scores is 10-60, with higher scores indicating greater perceived barriers to seeking care. |
At baseline (T0), 3 months (T1) and 12 months (T2) post-programme
|
|
Symptom onset-to-door (O2D) time among participants experiencing an AMI episode
Временное ограничение: 12 months following enrolment
|
O2D time, defined as the interval between the onset of ischaemic symptoms and hospital arrival will be determined through patient recall, using a benchmarking technique that associates symptom onset with daily routines to improve recall accuracy. The hospital arrival times will be verified from medical records. |
12 months following enrolment
|
|
Ambulance use for transport to hospital among participants experiencing an AMI episode
Временное ограничение: 12 months following enrolment
|
The proportion of participants who used emergency ambulance services (versus other transport modes) to reach hospital during an AMI episode will be collected from reviewing medical records. |
12 months following enrolment
|
|
In-hospital and 30-day major adverse cardiovascular and cerebrovascular events (MACCEs)
Временное ограничение: 12 months following enrolment
|
In-hospital and 30-day MACCEs, including cardiac- and non-cardiac-related mortality, malignant arrhythmias, recurrent AMI, unplanned coronary interventions or surgeries, new onset heart failure, and stroke, will be extracted from medical records according to the Standardized Data Collection for Cardiovascular Trials Initiative guidelines. |
12 months following enrolment
|
|
Length of hospital stay among participants experiencing an AMI episode
Временное ограничение: 12 months following enrolment
|
Total length of the index hospital stay (in days) following an AMI episode, will be collected from reviewing medical records. |
12 months following enrolment
|
|
Unplanned 30-day hospital readmissions among participants experiencing an AMI episode
Временное ограничение: 12 months following enrolment
|
The unplanned hospital readmissions within 30 days of discharge following an AMI episode, will be collected from reviewing medical records. |
12 months following enrolment
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Reach of the BE-Prepared programme
Временное ограничение: Through study completion, 3 years since commencement
|
The reach of the target population will be assessed by recording the number of eligible participants and those who participate in the BE-Prepared programme. |
Through study completion, 3 years since commencement
|
|
Adoption and engagement with the BE-Prepared programme
Временное ограничение: Over the 5-week intervention delivery period
|
Adoption will be assessed by documented attendance at the face-to-face session and the real-time online sessions. User engagement with programme materials will be tracked by the number of video views, the number of responses to embedded quizzes, and the average frequency and duration of viewing the programme materials. |
Over the 5-week intervention delivery period
|
|
Implementation of the BE-Prepared programme
Временное ограничение: Over the 5-week intervention delivery period and upon completion
|
The implementation of the programme will be evaluated through assessing the adherence to the intended delivery protocol by two independent reviewers against a fidelity checklist, qualitative interviews with 30 participants and a self-developed 10-item participant satisfaction survey. |
Over the 5-week intervention delivery period and upon completion
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Polly Wai Chi Li, PhD, The University of Hong Kong, School of Nursing
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
- Сосудистые заболевания
- Сердечно-сосудистые заболевания
- Сердечные заболевания
- Артериосклероз
- Артериальные окклюзионные заболевания
- Коронарная болезнь
- Ишемия миокарда
- Поведение
- Приверженность и соблюдение режима лечения
- Поведение в отношении здоровья
- Соблюдение пациентом
- Принятие пациентом медицинской помощи
- Вмешательства приверженности
- Приверженность к лечению
- Ишемическая болезнь сердца
- Санитарное просвещение
Другие идентификационные номера исследования
- UW 25-557
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .